跳至主要内容
临床试验/IRCT20210706051800N1
IRCT20210706051800N1招募中2 期

FLOT induction chemotherapy before neoadjuvant chemoradiotherapy and resectability and pathologic response in patients with esophagogastric junction and Proximal gastric adenocarcinomas

Mashhad University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Appropriate performance status(ECOG score0-1)
  • Presence of pathologic diagnosis based on adenocarcinoma of the distal of esophagus and the proximal of stomach and the esophago-gastric junction
  • Resectable malignant lesion(stageIB-IIIB)

排除标准

  • Presence of siginificant comorbidity included uncontrolled diabetus mellitus,uncontrolled hypertension,history of ischemic heart disease and CABG,history of cerebrovascular accident(CVA),grade 2 or more neuropathy, failure of bone marrow(lymphopenia and leukopenia and thrombocytopenia in initial review),heart failure(EF=45%),renal dysfunction(GFR<50 mg/m),hepatic dysfunction (AST/ALT=3×ULN ? Billt=1.5×ULN) which prevents the prescription of neoadjuvant or surgery for the patient
  • History of collagen vascular disease
  • Presence of metastatic disease in initial review
  • History of previous chemotherapy or radiotherapy
  • History of malignancy of solid organs during the last 5 years( except skin BCC/SCC and cervical CIN which were treated with surgery
  • Advanced inoperable cancer
  • Pregnancy and breastfeeding

研究者

相似试验

effect of chemotherapy befor chemoradiation on... | 临床试验